Home › Companies › Pharmaceuticals and biotechnology › United States
Is IOVANCE BIOTHERAPEUTICS, INC. (IOVA) stock halal?
Above the AAOIFI thresholds; 2 more lenient standards admit it.
This verdict follows the median view, that of AAOIFI Standard No. 21. It is based on the financial statements for the fiscal year ended 12/31/2025.
The ratios
| Criterion | Measure | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.2% of market capitalization | 30% | within threshold |
| Interest-bearing investments | 55.5% of market capitalization | 30% | threshold exceeded |
| Impermissible income | 3.9% of revenue | 5% | within threshold |
Standard: AAOIFI, Standard No. 21.
Margin to threshold and trend
| Item | Ratio (fiscal year end) | Threshold (AAOIFI, Standard No. 21) | Margin | Change since year end | Estimated ratio |
|---|---|---|---|---|---|
| Interest-bearing debt | 0.2% | 30% | 29.8% | not read | — |
| Interest-bearing investments | 55.5% | 30% | −25.5% | +0.2% | 55.6% |
Change read from the quarterly financial statements filed with the SEC (form 10-Q ended 06/30/2026, 2 quarters after fiscal year end), with the same reader on both dates. The estimated ratio applies this change to the annual ratio, with market capitalization unchanged: it is an estimate, not a verdict. "On watch" flags a permitted company whose estimated ratio reaches the threshold, or is within 5 points of the threshold and rising. This is neither a forecast nor advice.
The three views
- Median view, our reference : the company is excluded.
- Strictest view : the company is excluded, because it borrows or invests at interest.
- Most lenient view : the company is admitted (Al Rajhi, Albilad Capital).
Business activity
Biological Products, (No Diagnostic Substances) (SIC code 2836)
Financial statements read
Fiscal year ended 12/31/2025, in millions of dollars. Source: SEC EDGAR: annual reports of IOVANCE BIOTHERAPEUTICS, INC..
What could not be verified
- Activity classified from the SEC sector code, without reading the annual report.
- Figures read automatically and not reviewed by a human.
Status history
Loading history…
In the same sector
- ELI LILLY & Co Questionable
- JOHNSON & JOHNSON Permitted
- AbbVie Inc. Permitted
- Merck & Co., Inc. Permitted
- AMGEN INC Prohibited
- GILEAD SCIENCES, INC. Permitted
- ABBOTT LABORATORIES Permitted
- PFIZER INC Questionable
Compliance comparison only: no opinion on the value of these securities.
General information: neither investment advice nor a fatwa. Verdict calculated by published rules, from financial statements read automatically and not reviewed by a human. Read the methodology